The coexistence of EGFR mutations and ALK rearrangements in NSCLC remains a subject of debate, with theories suggesting that the two alterations may either exist in different cells within the same tumor or in the same cells [152,153]. Here, ALK is linked to non-small cell lung carcinoma.